NHS Greater Glasgow & Clyde Area Drug and Therapeutics Committee
Greater Glasgow and Clyde Medicines
Medicines Update

Post-MI LVSD Teach and Treat

Following agreement between NHS Education for Scotland (NES), cardiology and pharmacy services in NHSGGC (September 2013), patients with left ventricular systolic dysfunction following myocardial infarction have been referred to dedicated pharmacist clinics for medicines optimisation. Patients are routinely identified by Cardiac Rehabilitation Nurses. This service now operates across NHSGGC.

  • In the three years to September 2016, 708 patients were referred to the service
  • 553 (78%) have been reviewed and discharged
  • 82 patients have been referred onwards from specialist to primary care clinics for further optimisation of secondary prevention
  • 2349 pharmacist reviews have been completed. 103 patients remain under review at the time of audit
  • Rates of attendance and patient satisfaction with the clinic are extremely high

Following an average of 4.6 appointments per patient, optimisation of standard secondary prevention is outlined in Table 1 below:

 

ACEI

Prescribed

Mean Target*

ACEI Dose

Beta-blocker

Prescribed

Mean Target*

Beta-blocker Dose

Baseline Audit

90.75%

49%

88.5%

33.5%

Pharmacist Clinic

97%

80%

92%

51%

*European Society of Cardiology recommended target dose

The service continues to develop in NHSGGC in collaboration with acute and primary care teams. More primary care pharmacists are being trained to deliver local clinics in health centres and general practice. Consistent with Prescription for Excellence strategy, NES has funded national expansion of this clinic model. This is scheduled to commence in other Health Boards during 2017-18.

 

Published 27/07/2017